Cancer Nanotechnology

Basic, translational and clinical research

Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Read our Editorial to learn more

Cancer Nanotechnology accepted for inclusion in SCIE

New Content Item We are delighted to announce that Cancer Nanotechnology has been accepted for inclusion in Science Citation Index Expanded (SCIE), a key database of Web of Science, published by Clarivate Analytics.

Starting 2020, Cancer Nanotechnology will be published in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score and Journal Impact Factor.

We would like to thank everyone for supporting Cancer Nanotechnology and contributing to this success.

Call for papers – Precision Oncology

We are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to help bring together the latest research on precision oncology.

The thematic series is now open for submission of original research and review articles - for further information about this series please click the link above.

Article collections

Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far by clicking the link above.

We welcome further submissions to these collections.

Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!

Content type: Research
| 20 December 2018

Comb-like PEG-containing polymeric composition as low toxic drug nanocarrier

Authors: Lesya Kobylinska, Igor Patereha, Natalia Finiuk, Natalia Mitina, Anna Riabtseva, Igor Kotsyumbas, Rostyslav Stoika, Alexander Zaichenko and Sandor G. Vari
Content type: Review
| 21 November 2018

Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Authors: Lindsey A. Bennie, Helen O. McCarthy and Jonathan A. Coulter
Content type: Research
| 9 November 2018

Towards photon radiotherapy treatment planning with high Z nanoparticle radiosensitisation agents: the Relative Biological Effective Dose (RBED) framework

Authors: Jeremy M. C. Brown, Gerard G. Hanna, Nathanael Lampe, Balder Villagomez-Bernabe, James R. Nicol, Jonathan A. Coulter and Fred J. Currell
Content type: Research
| 31 October 2018

C₆₀ fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes

Authors: Larysa M. Skivka, Svitlana V. Prylutska, Mariia P. Rudyk, Nataliia M. Khranovska, Ievgeniia V. Opeida, Vasyl V. Hurmach, Yuriy I. Prylutskyy, Leonid F. Sukhodub and Uwe Ritter
Content type: Research
| 8 October 2018

Magnetic hyperthermia of breast cancer cells and MRI relaxometry with dendrimer-coated iron-oxide nanoparticles

Authors: Marzieh Salimi, Saeed Sarkar, Reza Saber, Hamid Delavari, Ali Mohammad Alizadeh and Hendrik Thijmen Mulder

Most recent articles RSS

View all articles

Content type: Review
| 21 November 2017

Particle therapy and nanomedicine: state of art and research perspectives

Authors: Sandrine Lacombe, Erika Porcel and Emanuele Scifoni
Content type: Review
| 2 February 2017

Biological mechanisms of gold nanoparticle radiosensitization

Authors: Soraia Rosa, Chris Connolly, Giuseppe Schettino, Karl T. Butterworth and Kevin M. Prise
Content type: Research
| 3 August 2018

Cisplatin-loaded hollow gold nanoparticles for laser-triggered release

Authors: Chiyi Xiong, Wei Lu, Min Zhou, Xiaoxia Wen and Chun Li
Content type: Research
| 1 July 2014

Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment

Authors: Géraldine Le Duc, Stéphane Roux, Amandine Paruta-Tuarez, Sandrine Dufort, Elke Brauer, Arthur Marais, Charles Truillet, Lucie Sancey, Pascal Perriat, François Lux and Olivier Tillement
Content type: Review
| 3 November 2016

Gold nanoparticles for cancer radiotherapy: a review

Authors: Kaspar Haume, Soraia Rosa, Sophie Grellet, Małgorzata A. Śmiałek, Karl T. Butterworth, Andrey V. Solov’yov, Kevin M. Prise, Jon Golding and Nigel J. Mason

Most accessed articles RSS

View all articles

Stay up to date

Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC.

Part of the BMC family

Cancer Nanotechnology is now part of the BMC family of journals. The BMC website receives over 100 million views per year and is a pioneer of open access publishing. Bookmark the new URL and sign up to article alerts to stay up-to-date about what's happening in Cancer Nanotechnology.

Learn more about BMC by visiting the homepage

Latest Tweets

Cancer Nanotechnology

Basic, translational and clinical research